tiprankstipranks
Trending News
More News >
Procter & Gamble Company (PG)
:PG
Advertisement

Procter & Gamble (PG) AI Stock Analysis

Compare
15,498 Followers

Top Page

PG

Procter & Gamble

(NYSE:PG)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
$176.00
▲(15.41% Upside)
Procter & Gamble's strong financial performance and resilience in challenging conditions are significant strengths. However, high valuation, macroeconomic challenges, and slowing growth rates temper the overall outlook. The company's strategic focus on restructuring and e-commerce provides potential for future growth.
Positive Factors
Strong Financial Health
P&G's robust financial health, marked by consistent profitability and stable cash flow, ensures long-term operational stability and resilience against economic fluctuations.
E-commerce Growth
The significant growth in e-commerce sales highlights P&G's successful adaptation to digital retail trends, expanding its market reach and customer base.
Product Innovation
P&G's strong performance in product innovation underscores its ability to meet consumer demands and maintain competitive advantage through new offerings.
Negative Factors
Slowing Revenue Growth
The slowing revenue growth rate may indicate challenges in expanding market share, potentially impacting long-term growth prospects if not addressed.
Inventory Reductions
Inventory reductions by retailers can lead to decreased sales and disrupt supply chain efficiency, affecting P&G's ability to meet demand promptly.
Tariff and Currency Headwinds
Tariff and currency headwinds pose risks to cost management and profitability, potentially impacting P&G's global operations and financial performance.

Procter & Gamble (PG) vs. SPDR S&P 500 ETF (SPY)

Procter & Gamble Business Overview & Revenue Model

Company DescriptionThe Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
How the Company Makes MoneyProcter & Gamble generates revenue primarily through the sale of its consumer goods products across its various sectors. The company operates on a direct-to-consumer model as well as through retail partnerships, including large chains and online platforms. Key revenue streams include sales from personal care products, household cleaning supplies, and health care items. P&G invests significantly in marketing and brand development to maintain a strong presence in the market, which helps drive consumer loyalty and repeat purchases. Additionally, strategic partnerships with retailers and e-commerce platforms enhance distribution and accessibility of its products, further contributing to its earnings.

Procter & Gamble Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Shows sales performance across various divisions, indicating which areas are growing or declining and how the company is diversifying its revenue streams.
Chart InsightsProcter & Gamble's Fabric and Homecare segment shows consistent growth, reflecting strong demand and successful product launches like the Swiffer PowerMop. However, the Baby, Feminine, and Familycare segment faces volatility, with recent declines. The earnings call highlights challenges such as tariffs and inventory adjustments in the U.S., which could impact future performance. Despite these, P&G's focus on innovation and restructuring aims to bolster its market position, with a strategic emphasis on product superiority and shareholder returns amid macroeconomic uncertainties.
Data provided by:Main Street Data

Procter & Gamble Earnings Call Summary

Earnings Call Date:Jul 29, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Oct 24, 2025
Earnings Call Sentiment Neutral
P&G demonstrated resilience amidst challenging economic conditions by maintaining stable organic sales growth, strong e-commerce performance, and a significant cash return to shareholders. However, they faced notable challenges in Greater China, inventory reductions, and tariff impacts, leading to a balanced sentiment for the earnings call.
Q4-2025 Updates
Positive Updates
Stable Organic Sales Growth
Organic sales grew 2% for the fiscal year 2025, with nine of ten product categories showing growth.
Strong E-commerce Performance
E-commerce sales increased by 12%, now representing 19% of total company sales.
Healthy Cash Return to Shareholders
Returned $16 billion to shareholders through dividends and share repurchases, in line with guidance.
Successful Product Innovations
P&G earned 4 of the top 10 spots for successful nonfood product launches in the Circana U.S. New Products Pacesetters report.
Significant Organizational Restructuring
Announced a two-year restructuring program aimed at reducing up to 7,000 nonmanufacturing roles to enhance operational efficiency.
Negative Updates
Challenges in Greater China
Greater China organic sales were down 5% for the year, though they showed sequential improvement by growing 2% in the most recent quarter.
Inventory Reductions Impact Sales
Sell-in trail sell-out due to retailer inventory reductions, particularly affecting North America.
Tariff Impacts and Currency Challenges
Faced a $1 billion headwind from tariffs in fiscal '26 and significant currency challenges.
Slower Category Growth
Deceleration in category growth rates, particularly in the U.S. and Europe, with consumer consumption trends showing consistent slowdown.
Company Guidance
In the recent Procter & Gamble (P&G) conference call, the company provided guidance for fiscal year 2026, anticipating a challenging environment due to ongoing macroeconomic, geopolitical, and consumer dynamics. Despite these challenges, P&G aims for organic sales growth within a range of flat to 4% compared to the previous year, acknowledging a 30 to 50 basis point headwind from brand and product form discontinuations as part of a two-year restructuring program. The company expects core EPS growth to range from flat to 4%, equating to $6.83 to $7.09 per share, with a midpoint of $6.96. P&G also anticipates a $200 million commodity cost headwind and a $300 million foreign exchange tailwind, along with a $1 billion pre-tax impact from tariffs. The company plans to return approximately $15 billion in cash to shareholders through dividends and share repurchases and projects adjusted free cash flow productivity between 85% and 90%. The restructuring program, aimed at improving competitiveness and execution, is expected to yield up to 7,000 non-manufacturing role reductions over two years.

Procter & Gamble Financial Statement Overview

Summary
Procter & Gamble demonstrates strong financial health with consistent profitability, effective leverage management, and stable cash flow generation. The company maintains robust profit margins and a solid balance sheet, though growth rates have slowed, and free cash flow has declined, warranting attention.
Income Statement
85
Very Positive
Procter & Gamble has demonstrated consistent revenue growth over the years, with a revenue growth rate of 0.29% in the most recent year, indicating stability in its top-line performance. The company maintains strong profitability metrics, with a gross profit margin of 51.15% and a net profit margin of 18.95% in 2025. The EBIT margin at 24.25% and EBITDA margin at 25.00% further underscore its operational efficiency. However, the growth rate has slowed compared to previous years, which could be a point of concern if the trend continues.
Balance Sheet
78
Positive
Procter & Gamble exhibits a solid balance sheet with a debt-to-equity ratio of 0.66, indicating a balanced approach to leverage. The return on equity stands at 30.54%, reflecting efficient use of shareholders' equity to generate profits. The equity ratio of 41.73% shows a healthy proportion of assets funded by equity, enhancing financial stability. Despite the strong metrics, the company should monitor its debt levels, which have slightly increased in absolute terms.
Cash Flow
82
Very Positive
The company maintains robust cash flow generation, evidenced by the operating cash flow to net income ratio of 1.12, indicating effective cash conversion from profits. The free cash flow to net income ratio is 0.88, showcasing the ability to generate cash after capital expenditures. However, the free cash flow has declined by 15.01% from the previous year, which could impact future flexibility if this trend continues.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue84.28B84.28B84.04B82.01B80.19B76.12B
Gross Profit43.12B43.12B43.19B39.25B38.03B39.01B
EBITDA21.07B23.92B22.58B21.77B21.24B20.85B
Net Income15.97B15.97B14.88B14.65B14.74B14.31B
Balance Sheet
Total Assets125.23B125.23B122.37B120.83B117.21B119.31B
Cash, Cash Equivalents and Short-Term Investments9.56B9.56B9.48B8.25B7.21B10.29B
Total Debt34.51B35.46B33.37B35.42B32.29B32.84B
Total Liabilities72.95B72.95B71.81B73.76B70.35B72.65B
Stockholders Equity52.01B52.01B50.29B46.78B46.59B46.38B
Cash Flow
Free Cash Flow14.04B14.04B16.52B13.79B13.57B15.58B
Operating Cash Flow17.82B17.82B19.85B16.85B16.72B18.37B
Investing Cash Flow-3.82B-3.82B-3.50B-3.50B-4.42B-2.83B
Financing Cash Flow-14.04B-14.04B-14.86B-12.15B-14.88B-21.53B

Procter & Gamble Technical Analysis

Technical Analysis Sentiment
Negative
Last Price152.50
Price Trends
50DMA
155.96
Negative
100DMA
158.05
Negative
200DMA
161.41
Negative
Market Momentum
MACD
-1.08
Positive
RSI
38.35
Neutral
STOCH
12.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PG, the sentiment is Negative. The current price of 152.5 is below the 20-day moving average (MA) of 156.80, below the 50-day MA of 155.96, and below the 200-day MA of 161.41, indicating a bearish trend. The MACD of -1.08 indicates Positive momentum. The RSI at 38.35 is Neutral, neither overbought nor oversold. The STOCH value of 12.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PG.

Procter & Gamble Risk Analysis

Procter & Gamble disclosed 20 risk factors in its most recent earnings report. Procter & Gamble reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Procter & Gamble Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$356.92B23.4331.23%2.71%0.29%7.85%
71
Outperform
$145.26B24.2028.73%3.35%-0.30%-14.60%
63
Neutral
$64.33B22.37414.39%2.56%0.05%3.55%
59
Neutral
$31.51B22.3110.65%5.01%-2.15%26.65%
57
Neutral
$40.55B16.85191.19%4.09%-6.89%7.52%
50
Neutral
$31.19B-27.54-29.31%1.62%-8.14%-389.12%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PG
Procter & Gamble
152.50
-16.43
-9.73%
CL
Colgate-Palmolive
79.59
-21.94
-21.61%
EL
The Estée Lauder Companies
86.66
-11.20
-11.44%
KMB
Kimberly Clark
122.23
-14.89
-10.86%
UL
Unilever
59.28
-3.58
-5.70%
KVUE
Kenvue, Inc.
16.42
-5.87
-26.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 19, 2025